- Home
- IZEA vs BYSI Comparison
IZEA vs BYSI Comparison
Compare IZEA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZEA
- BYSI
- Stock Information
- Founded
- IZEA 2006
- BYSI 2010
- Country
- IZEA United States
- BYSI United States
- Employees
- IZEA N/A
- BYSI N/A
- Industry
- IZEA Advertising
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- IZEA Consumer Discretionary
- BYSI Health Care
- Exchange
- IZEA Nasdaq
- BYSI Nasdaq
- Market Cap
- IZEA 69.1M
- BYSI 73.4M
- IPO Year
- IZEA N/A
- BYSI 2017
- Fundamental
- Price
- IZEA $4.95
- BYSI $1.95
- Analyst Decision
- IZEA
- BYSI
- Analyst Count
- IZEA 0
- BYSI 0
- Target Price
- IZEA N/A
- BYSI N/A
- AVG Volume (30 Days)
- IZEA 316.4K
- BYSI 52.6K
- Earning Date
- IZEA 11-12-2025
- BYSI 11-13-2025
- Dividend Yield
- IZEA N/A
- BYSI N/A
- EPS Growth
- IZEA N/A
- BYSI N/A
- EPS
- IZEA N/A
- BYSI N/A
- Revenue
- IZEA $36,935,906.00
- BYSI N/A
- Revenue This Year
- IZEA $11.15
- BYSI N/A
- Revenue Next Year
- IZEA $17.64
- BYSI N/A
- P/E Ratio
- IZEA N/A
- BYSI N/A
- Revenue Growth
- IZEA 12.49
- BYSI N/A
- 52 Week Low
- IZEA $1.68
- BYSI $0.98
- 52 Week High
- IZEA $5.86
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- IZEA 52.14
- BYSI 53.34
- Support Level
- IZEA $5.03
- BYSI $1.77
- Resistance Level
- IZEA $5.29
- BYSI $2.26
- Average True Range (ATR)
- IZEA 0.31
- BYSI 0.17
- MACD
- IZEA -0.09
- BYSI 0.01
- Stochastic Oscillator
- IZEA 21.70
- BYSI 40.91
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.